BioAge Labs Inc. News

Latest updates and market news for BIOA

2 news

Jan 9 - Jan 15, 2026

Page 1

BioAge Rockets As It Takes On Eli Lilly's Takeover Play, Ventyx Bio

Investor's Business Daily

2 days ago

BioAge Rockets As It Takes On Eli Lilly's Takeover Play, Ventyx Bio

📈

AI Sentiment

Highly Positive

9/10

BioAge Announces Additional Positive Interim Phase 1 Data for BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor, Demonstrating Potential for Best-in-Class hsCRP Reduction in Participants with Elevated Cardiovascular Risk

GlobeNewswire

3 days ago

BioAge Announces Additional Positive Interim Phase 1 Data for BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor, Demonstrating Potential for Best-in-Class hsCRP Reduction in Participants with Elevated Cardiovascular Risk

📈

AI Sentiment

Highly Positive

9/10

Share this news page

Share on Social Networks: